価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Resistin, Human, ELISA Kit (96well)
データシート
RD191016100 BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥95,000
(未発注)
追加

在庫・価格 : 2025年04月26日 08時45分 現在

Resistin, Human, ELISA Kit (96well)

  • 商品コード:RD191016100
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥95,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fain JN et al. Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 2003 Jan;300(3):674-8
Fain JN et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
2 Hegele RA et al. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler. Thromb. Vasc. Biol. 2003 Jan;23(1):111-6
Hegele RA et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
3 Stejskal D et al. Preliminary experience with resistin assessment in common population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002 Dec;146(2):47-9
Stejskal D et al
2002/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
4 Yura S et al. Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 2003 Mar;88(3):1394-7
Yura S et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
5 Yannakoulia M et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 2003 Apr;88(4):1730-6
Yannakoulia M et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
6 Silha JV et al. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin. Endocrinol. (Oxf) 2003 Jun;58(6):736-42
Silha JV et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
7 Kielstein JT et al. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am. J. Kidney Dis. 2003 Jul;42(1):62-6
Kielstein JT et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
8 Azuma K et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 2003 Aug;11(8):997-1001
Azuma K et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
9 Monzillo LU et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 2003 Sep;11(9):1048-54
Monzillo LU et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
10 . Abstracts of the 18th International Diabetes Federation Congress. Paris, France, 24-29 August 2003. Diabetes Metab. 2003 Aug;29 Spec No 2:4S7-464

2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
11 Furuhashi M et al. Circulating resistin levels in essential hypertension. Clin. Endocrinol. (Oxf) 2003 Oct;59(4):507-10
Furuhashi M et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
12 Silha JV et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 2003 Oct;149(4):331-5
Silha JV et al
2003/01/01
PubMed
13 Sch辰ffler A et al. Adipocytokines in synovial fluid. JAMA 2003 Oct;290(13):1709-10
Sch辰ffler A et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
14 Lee JH et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subj
Lee JH et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
15 Degawa-Yamauchi M et al. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 2003 Nov;88(11):5452-5
Degawa-Yamauchi M et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
16 Fujinami A et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 2004 Jan;339(1-2):57-63
Fujinami A et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
17 Krsek M et al. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin. Endocrinol. (Oxf) 2004 Mar;60(3):350-7
Krsek M et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
18 Bajaj M et al. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int. J. Obes. Relat. Metab. Disord. 2004 Jun;28(6):783-9
Bajaj M et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
19 Stejskal D et al. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Nov;147(1):63-9
Stejskal D et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
20 Stejskal D et al. Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):167-72
Stejskal D et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
21 Hana V et al. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin. Endocrinol. (Oxf) 2004 Apr;60(4):442-50
Hana V et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
22 Heilbronn LK et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004 Apr;89(4):1844-8
Heilbronn LK et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
23 Al-Mrayat M et al. A new cause of neuroglycopenia: "missing the point". Diabet. Med. 2004 May;21(5):497
Al-Mrayat M et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
24 Silha JV et al. Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet. Med. 2004 May;21(5):497-9
Silha JV et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
25 Vozarova de Courten B et al. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004 May;53(5):1279-84
Vozarova de Courten B et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
26 Tejero ME et al. Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons. Obes. Res. 2004 May;12(5):871-7
Tejero ME et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
27 Vendrell J et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 2004 Jun;12(6):962-71
Vendrell J et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
28 Meier U et al. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 2004 Sep;50(9):1511-25
Meier U et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
29 Azuma K et al. Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm. Metab. Res. 2004 Aug;36(8):564-70
Azuma K et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
30 Wolfe BE et al. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. (Oxf) 2004 Sep;61(3):332-8
Wolfe BE et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
31 Chen D et al. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin. Sci. 2005 Jan;108(1):81-4
Chen D et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
32 Shetty GK et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004 Oct;27(10):2450-7
Shetty GK et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
33 Sch辰ffler A et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm. Metab. Res. 2004 Oct;36(10):702-7
Sch辰ffler A et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
34 Lehrke M et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004 Nov;1(2):e45
Lehrke M et al
2004/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
35 Housova J et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J. Clin. Endocrinol. Metab. 2005 Mar;90(3):1366-70
Housova J et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
36 Svensson J et al. Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults. J. Clin. Endocrinol. Metab. 2005 Apr;90(4):2290-6
Svensson J et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
37 Reilly MP et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 Feb;111(7):932-9
Reilly MP et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
38 Housov叩 J et al. Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res 2005;54(1):73-8
Housov叩 J et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
39 Carmina E et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur. J. Endocrinol. 2005 Mar;152(3):389-94
Carmina E et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
40 Chen CC et al. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metab. Clin. Exp. 2005 Apr;54(4):471-5
Chen CC et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
41 Bokarewa M et al. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005 May;174(9):5789-95
Bokarewa M et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
42 Pagano C et al. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. J. Clin. Endocrinol. Metab. 2005 Jul;90(7):4335-40
Pagano C et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
43 Sopasakis VR et al. Cytokine release from adipose tissue of nonobese individuals. Int J Obes (Lond) 2005 Sep;29(9):1144-7
Sopasakis VR et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
44 Gerber M et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4503-9
Gerber M et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
45 Pilz S et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4792-6
Pilz S et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
46 Verhaeghe J et al. Adipokine profile and C-reactive protein in pregnancy: effects of glucose challenge response versus body mass index. J. Soc. Gynecol. Investig. 2005 Jul;12(5):330-4
Verhaeghe J et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
47 Faeh D et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005 Jul;54(7):1907-13
Faeh D et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
48 Ohmori R et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J. Am. Coll. Cardiol. 2005 Jul;46(2):379-80
Ohmori R et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
49 Bo S et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond) 2005 Nov;29(11):1315-20
Bo S et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
50 Vilarrasa N et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin. Endocrinol. (Oxf) 2005 Sep;63(3):329-35
Vilarrasa N et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
51 Haugen F et al. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am. J. Physiol. Endocrinol. Metab. 2006 Feb;290(2):E326-33
Haugen F et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
52 N端sken KD et al. Circulating resistin concentrations in children depend on renal function. Nephrol. Dial. Transplant. 2006 Jan;21(1):107-12
N端sken KD et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
53 Burnett MS et al. The potential role of resistin in atherogenesis. Atherosclerosis 2005 Oct;182(2):241-8
Burnett MS et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
54 Musso G et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005 Nov;42(5):1175-83
Musso G et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
55 Burnett MS et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J. Clin. Endocrinol. Metab. 2006 Jan;91(1):64-8
Burnett MS et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
56 Perseghin G et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005 Dec;48(12):2615-21
Perseghin G et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
57 Pischon T et al. Association of plasma resistin levels with coronary heart disease in women. Obes. Res. 2005 Oct;13(10):1764-71
Pischon T et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
58 Wong SP et al. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Diabetologia 2005 Dec;48(12):2641-9
Wong SP et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
59 Bergheim I et al. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J. Pharmacol. Exp. Ther. 2006 Mar;316(3):1053-61
Bergheim I et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
60 Chu MC et al. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am. J. Obstet. Gynecol. 2006 Jan;194(1):100-4
Chu MC et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
61 Pagano C et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):1081-6
Pagano C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
62 Pravenec M et al. Fat-specific transgenic expression of resistin in the spontaneously hypertensive rat impairs fatty acid re-esterification. Int J Obes (Lond) 2006 Jul;30(7):1157-9
Pravenec M et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
63 Nystr旦m T et al. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin. Sci. 2006 Jun;110(6):673-81
Nystr旦m T et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
64 Koebnick C et al. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism. Int J Obes (Lond) 2006 Jul;30(7):1097-103
Koebnick C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
65 Bahr MJ et al. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2006 Aug;291(2):E199-206
Bahr MJ et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
66 Beulens JW et al. The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring) 2006 Jan;14(1):60-6
Beulens JW et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
67 Rae C et al. Human resistin promotes macrophage lipid accumulation. Diabetologia 2006 May;49(5):1112-4
Rae C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
68 Carmina E et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am. J. Med. 2006 Apr;119(4):356.e1-6
Carmina E et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
69 Lu HL et al. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J. Gastroenterol. 2006 Mar;12(11):1747-51
Lu HL et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
70 Menzaghi C et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J. Clin. Endocrinol. Metab. 2006 Jul;91(7):2792-5
Menzaghi C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
71 Perseghin G et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am. J. Physiol. Endocrinol. Metab. 2006 Oct;291(4):E697-703
Perseghin G et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
72 Perseghin G et al. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 2006 Aug;49(8):1893-900
Perseghin G et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
73 Redondo C et al. The retinol-binding protein system: a potential paradigm for steroid-binding globulins? Horm. Metab. Res. 2006 Apr;38(4):269-78
Redondo C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
74 Yagmur E et al. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am. J. Gastroenterol. 2006 Jun;101(6):1244-52
Yagmur E et al
2006/01/01
PubMed
75 Paul G et al. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm. Bowel Dis. 2006 Jun;12(6):471-7
Paul G et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
76 Gambino R et al. RETRACTED: Postprandial lipemia and LDL conjugated dienes predict serum GGT and liver histology in NASH. Atherosclerosis 2006 Jun;
Gambino R et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
77 Lubos E et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 2007 Jul;193(1):121-8
Lubos E et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
78 Westphal S et al. Extended-release niacin raises adiponectin and leptin. Atherosclerosis 2007 Aug;193(2):361-5
Westphal S et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
79 Kremen J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4620-7
Kremen J et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
80 Martos-Moreno GA et al. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur. J. Endocrinol. 2006 Sep;155(3):429-34
Martos-Moreno GA et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
81 Musso G et al. Retraction: The Postprandial Phase as a Link Between Systemic Lipid Peroxidation and Liver Injury in NASH. Am. J. Gastroenterol. 2006 Sep;
Musso G et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
82 Risch L et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin. Chim. Acta 2007 Feb;376(1-2):108-13
Risch L et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
83 Perseghin G et al. Serum resistin and hepatic fat content in nondiabetic individuals. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):5122-5
Perseghin G et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
84 de Luis Roman D et al. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch. Med. Res. 2006 Oct;37(7):854-9
de Luis Roman D et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
85 Westphal S et al. Adipokines and treatment with niacin. Metab. Clin. Exp. 2006 Oct;55(10):1283-5
Westphal S et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
86 Senolt L et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann. Rheum. Dis. 2007 Apr;66(4):458-63
Senolt L et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
87 Chu MC et al. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil. Steril. 2006 Dec;86(6):1669-75
Chu MC et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
88 Pamuk GE et al. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp. Oncol. 2006 Sep;28(3):241-4
Pamuk GE et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
89 Dolezalov叩 R et al. Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus. Physiol Res 2007;56(6):741-8
Dolezalov叩 R et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
90 Garcia AL et al. Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Horm. Metab. Res. 2006 Nov;38(11):761-6
Garcia AL et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
91 Hui-Bing H et al. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2006 Dec;55(12):1670-3
Hui-Bing H et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
92 Efstathiou SP et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin. Chim. Acta 2007 Mar;378(1-2):78-85
Efstathiou SP et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
93 Nagaev I et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006;1:e31
Nagaev I et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
94 Anderlov叩 K et al. Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes. Physiol Res 2007;56(5):579-86
Anderlov叩 K et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
95 Migita K et al. The serum levels of resistin in rheumatoid arthritis patients. Clin. Exp. Rheumatol. ;24(6):698-701
Migita K et al
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
96 de Luis DA et al. Effects of a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults. Horm. Res. 2007;67(6):296-300
de Luis DA et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
97 Sch辰ffler A et al. Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: pilot study. J. Gastroenterol. Hepatol. 2007 Mar;22(3):326-34
Sch辰ffler A et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
98 Pilz S et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin. Endocrinol. (Oxf) 2007 Mar;66(3):380-6
Pilz S et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
99 Cortelazzi D et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf) 2007 Mar;66(3):447-53
Cortelazzi D et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
100 Kadoglou NP et al. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007 Mar;30(3):719-21
Kadoglou NP et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
101 Mojiminiyi OA et al. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand. J. Clin. Lab. Invest. 2007;67(2):215-25
Mojiminiyi OA et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
102 Perseghin G et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 2007 Jun;30(6):1520-6
Perseghin G et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
103 Busetto L et al. The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 2008 Feb;18(2):112-20
Busetto L et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
104 Sund辿n-Cullberg J et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit. Care Med. 2007 Jun;35(6):1536-42
Sund辿n-Cullberg J et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
105 Derosa G et al. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone. J Clin Pharm Ther 2007 Jun;32(3):261-8
Derosa G et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
106 Tauman R et al. Adipokines in children with sleep disordered breathing. Sleep 2007 Apr;30(4):443-9
Tauman R et al
2007/01/01
PubMed
107 Chen D et al. Serum resistin in gestational diabetes mellitus and early postpartum. Clin. Endocrinol. (Oxf) 2007 Aug;67(2):208-11
Chen D et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
108 Kadoglou NP et al. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 2007 Sep;30(9):2242-4
Kadoglou NP et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
109 Escriv叩 F et al. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J. Endocrinol. 2007 Jul;194(1):131-41
Escriv叩 F et al
2007/01/01
PubMed
110 Weikert C et al. Within-subject variation of plasma resistin levels over a 1-year period. Clin. Chem. Lab. Med. 2007;45(7):899-902
Weikert C et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
111 Kovacić D et al. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. Clin Res Cardiol 2008 Jan;97(1):24-31
Kovacić D et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
112 Kr鱈zov叩 J et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res 2008;57(4):539-46
Kr鱈zov叩 J et al
2008/01/01
PubMed
113 Hoefle G et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin. Chim. Acta ;386(1-2):1-6
Hoefle G et al
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
114 Zhou L et al. Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. FEBS Lett. 2007 Sep;581(22):4303-8
Zhou L et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
115 Ellington AA et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 2007 Oct;50(4):708-14
Ellington AA et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
116 Musso G et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am. J. Clin. Nutr. 2007 Sep;86(3):661-
Musso G et al
2007/01/01
PubMed
117 Gambino R et al. Microsomal triglyceride transfer protein 493-T variant is associated with resistin levels and C-reactive protein. Clin. Biochem. 2007 Nov;40(16-17):1219-24
Gambino R et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
118 Kim SJ et al. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J. Biol. Chem. 2007 Nov;282(47):34139-47
Kim SJ et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
119 Corpeleijn E et al. Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM). Diabetes Care 2007 Dec;30(12):3125-7
Corpeleijn E et al
2007/01/01
PubMed
120 Krusinov叩 E et al. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur. J. Endocrinol. 2007 Oct;157(4):443-9
Krusinov叩 E et al
2007/01/01
PubMed
121 Aller R et al. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig. Dis. Sci. 2008 Apr;53(4):1088-92
Aller R et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
122 Dolezalova R et al. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin. Endocrinol. (Oxf) 2007 Nov;67(5):674-8
Dolezalova R et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
123 Lamounier-Zepter V et al. Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Mol. Cell. Endocrinol. 2008 Jan;280(1-2):39-46
Lamounier-Zepter V et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
124 Musso G et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008 Mar;31(3):562-8
Musso G et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
125 de Luis DA et al. Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch. Med. Res. 2008 Jan;39(1):110-4
de Luis DA et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
126 Jarrar MH et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008 Mar;27(5):412-21
Jarrar MH et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
127 Kakizaki S et al. Elevated plasma resistin concentrations in patients with liver cirrhosis. J. Gastroenterol. Hepatol. 2008 Jan;23(1):73-7
Kakizaki S et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
128 Annaloro C et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 May;41(9):797-804
Annaloro C et al
2008/01/01
PubMed
129 Megia A et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur. J. Endocrinol. 2008 Feb;158(2):173-8
Megia A et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
130 Musso G et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008 Apr;47(4):1167-77
Musso G et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
131 Chalvatzas N et al. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil. Steril. 2009 Apr;91(4):1189-94
Chalvatzas N et al
2009/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
132 Karapanagiotou EM et al. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008 Sep;61(3):391-7
Karapanagiotou EM et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
133 Barac A et al. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension. Am. J. Cardiol. 2008 Apr;101(7):980-5
Barac A et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
134 Saito T et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J. Dent. Res. 2008 Apr;87(4):319-22
Saito T et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
135 de Luis DA et al. Influence of Lys656Asn polymorphism of the leptin receptor gene on insulin resistance in nondiabetic obese patients. J. Diabetes Complicat. ;22(3):199-204
de Luis DA et al
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
136 Weikert C et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J. Clin. Endocrinol. Metab. 2008 Jul;93(7):2647-53
Weikert C et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
137 Koch TC et al. Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia. Eur J Nutr 2008 Apr;47(3):161-70
Koch TC et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
138 Dost叩lov叩 I et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3627-32
Dost叩lov叩 I et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
139 Dolinkov叩 M et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol. Cell. Endocrinol. 2008 Sep;291(1-2):63-70
Dolinkov叩 M et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
140 Tsochatzis E et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand. J. Gastroenterol. 2008;43(9):1128-36
Tsochatzis E et al
2008/01/01
PubMed
141 Mangge H et al. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2009 Mar;203(1):277-83
Mangge H et al
2009/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium PubMed
142 Haluz鱈kov叩 D et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009;58(4):577-81
Haluz鱈kov叩 D et al
2009/01/01
PubMed
143 J淡rgensen SB et al. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 2009 Jul;297(1):E57-66
J淡rgensen SB et al
2009/01/01
PubMed
144 Koch A et al. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009;13(3):R95
Koch A et al
2009/01/01
PubMed
145 Iacobellis G et al. Adipokines and cardiometabolic profile in primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 2010 May;95(5):2391-8
Iacobellis G et al
2010/01/01
PubMed
146 Durovcov叩 V et al. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome. Physiol Res 2010;59(6):963-71
Durovcov叩 V et al
2010/01/01
PubMed
147 Tuttolomondo A et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 2010;9:50
Tuttolomondo A et al
2010/01/01
PubMed
148 Gupta A et al. Interleukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: potential risk of metabolic syndrome. Hum Exp Toxicol 2011 Oct;30(10):1445-53
Gupta A et al
2011/01/01
PubMed
149 Aknc A et al. Association of cardiac changes with serum adiponectin and resistin levels in obese and overweight children. J Cardiovasc Med (Hagerstown) 2013 Mar;14(3):228-34
Aknc A et al
2013/01/01
PubMed
150 Aller R et al. Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. Nutr Hosp ;25(4):572-6
Aller R et al
PubMed
151 Asgeirsson T et al. Serum adiponectin, resistin, and circulating soluble receptor for advanced glycation end products in colectomy patients. Mediators Inflamm. 2011;2011:916807
Asgeirsson T et al
2011/01/01
PubMed
152 Auguet T et al. Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque. BMC Cardiovasc Disord 2016 07;16(1):149
Auguet T et al
2016/01/01
PubMed
153 Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
Auguet T et al
2011/01/01
PubMed
154 Bahijri SM et al. Supplementation with Oligonol, Prevents Weight Gain and Improves Lipid Profile in Overweight and Obese Saudi Females. Curr Nutr Food Sci 2018 Apr;14(2):164-170
Bahijri SM et al
2018/01/01
PubMed
155 BOSANSKA L et al. The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol Res 2009;58(3):319-25
BOSANSKA L et al
2009/01/01
PubMed
156 Broch M et al. Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Physiol Res 2010;59(2):299-303
Broch M et al
2010/01/01
PubMed
157 de Luis DA et al. Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets. J. Nut
de Luis DA et al
2013/01/01
PubMed
158 de Luis DA et al. Evaluation of weight loss and adipocytokines levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs9939609 gene variant. Diabetes Metab. Res. Rev. 2012 Nov;28(8):663-8
de Luis DA et al
2012/01/01
PubMed
159 de Luis DA et al. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. Eur Rev Med Pharmacol Sci ;13(6):413-8
de Luis DA et al
PubMed
160 Antonio de Luis D et al. The rs10401670 variant in resistin gene improved insulin resistance response and metabolic parameters secondaries to weight loss after a hypocaloric diet. Clin Nutr ESPEN 2016 08;14:14-18
Antonio de Luis D et al
2016/01/01
PubMed
161 de Luis DA et al. Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets. Ann. Nutr. Metab. 2009;54(2):104-10
de Luis DA et al
2009/01/01
PubMed
162 De Luis DA et al. Resistin levels and inflammatory markers in patients with morbid obesity. Nutr Hosp ;25(4):630-4
De Luis DA et al
PubMed
163 de Luis DA et al. Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients. Clin. Biochem. 2011 Nov;44(16):1280-3
de Luis DA et al
2011/01/01
PubMed
164 de Luis DA et al. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity. J Nutrigenet Nutrigenomics 2016;9(5-6):213-221
de Luis DA et al
2016/01/01
PubMed
165 de Luis DA et al. Polymorphism of neuropeptide Y gene rs16147 modifies the response to a hypocaloric diet on cardiovascular risk biomarkers and adipokines. J Hum Nutr Diet 2017 04;30(2):159-165
de Luis DA et al
2017/01/01
PubMed
166 de Luis DA et al. rs1501299 Polymorphism in the Adiponectin Gene and Their Association with Total Adiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects. Ann. Nutr. Metab. 2016;69(3-4):226-231
de Luis DA et al
2016/01/01
PubMed
167 Derosa G et al. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. J Pharm Pharm Sci 2010;13(3):378-90
Derosa G et al
2010/01/01
PubMed
168 Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
Derosa G et al
2011/01/01
PubMed
169 Derosa G et al. Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern. Med. 2010;49(16):1717-25
Derosa G et al
2010/01/01
PubMed
170 D鱈az-Soto G et al. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study. Diabetes Res. Clin. Pract. 2014 Apr;104(1):92-6
D鱈az-Soto G et al
2014/01/01
PubMed
171 ト志rovcovテ。 V et al. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome. Physiol Res 2010;59(3):415-422
ト志rovcovテ。 V et al
2010/01/01
PubMed
172 Filkov叩 M et al. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann. Rheum. Dis. 2009 Feb;68(2):295-6
Filkov叩 M et al
2009/01/01
PubMed
173 Garcia JM et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 2011 Jun;12(1):80
Garcia JM et al
2011/01/01
PubMed
174 Gharibeh MY et al. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 2010 Dec;36(6 Pt 1):443-9
Gharibeh MY et al
2010/01/01
PubMed
175 Gungor H et al. Association between resistin level and renal function in patients undergoing coronary artery bypass graft surgery. J Investig Med 2012 Aug;60(6):883-7
Gungor H et al
2012/01/01
PubMed
176 Gupta V et al. Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome. Toxicol Int 2011 Jul;18(2):168-72
Gupta V et al
2011/01/01
PubMed
177 Hulejov叩 H et al. No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. Clin. Rheumatol. 2012 Jan;31(1):67-71
Hulejov叩 H et al
2012/01/01
PubMed
178 Jurcovicov叩 J et al. Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis. Gen Physiol Biophys 2010 Mar;29(1):79-84
Jurcovicov叩 J et al
2010/01/01
PubMed
179 Kisacik B et al. Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acute appendicitis? Clin Rheumatol 2012 Feb;31(2):225-9
Kisacik B et al
2012/01/01
PubMed
180 Kleiblova P et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 2010 Jan;314(1):150-6
Kleiblova P et al
2010/01/01
PubMed
181 Kopeck箪 J et al. Selected adipokines - plasma concentrations and adipose tissue expressions during 24-hour lipid infusion in healthy men. Physiol Res 2010;59(1):89-96
Kopeck箪 J et al
2010/01/01
PubMed
182 Lien LF et al. The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. OMICS 2009 Feb;13(1):21-35
Lien LF et al
2009/01/01
PubMed
183 Liu X et al. Plasma Resistin Levels in Patients with Acute Aortic Dissection: A Propensity Score-Matched Observational Case-Control Study. Med Sci Monit 2018 Sep;24:6431-6437
Liu X et al
2018/01/01
PubMed
184 Mangge H et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795
Mangge H et al
2011/01/01
PubMed
185 Menzaghi C et al. Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals. Sci Rep 2017 Mar;7:44337
Menzaghi C et al
2017/01/01
PubMed
186 Menzaghi C et al. Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals. PLoS One 2012;7(6):e38414
Menzaghi C et al
2012/01/01
PubMed
187 Mojiminiyi OA et al. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract 2009;18(2):123-9
Mojiminiyi OA et al
2009/01/01
PubMed
188 Musso G et al. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty l
Musso G et al
2009/01/01
PubMed
189 Mutakin et al. Association between selenium nutritional status and metabolic risk factors in men with visceral obesity. J Trace Elem Med Biol 2013 Apr;27(2):112-6
Mutakin et al
2013/01/01
PubMed
190 Nakajima H et al. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch. Dermatol. Res. 2011 Aug;303(6):451-5
Nakajima H et al
2011/01/01
PubMed
191 Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009 Apr;9(4):311-26
Newgard CB et al
2009/01/01
PubMed
192 Papadopoulos DP et al. Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels. J Clin Hypertens (Greenwich) 2009 Feb;11(2):61-5
Papadopoulos DP et al
2009/01/01
PubMed
193 Pirola CJ et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2013 Sep;62(9):1356-63
Pirola CJ et al
2013/01/01
PubMed
194 Qi Q et al. Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels. Hum Mol Genet 2012 Nov;21(21):4774-80
Qi Q et al
2012/01/01
PubMed
195 Rank M et al. The cardio-metabolic risk of moderate and severe obesity in children and adolescents. J Pediatr 2013 Jul;163(1):137-42
Rank M et al
2013/01/01
PubMed
196 Roderburg C et al. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. J Crit Care 2013 Oct;28(5):882.e1-11
Roderburg C et al
2013/01/01
PubMed
197 Rozmilowska I et al. What is the role of adipokines in myasthenia gravis? Ther Clin Risk Manag 2018;14:1515-1525
Rozmilowska I et al
2018/01/01
PubMed
198 Rubino E et al. Investigating the role of adipokines in chronic migraine. Cephalalgia 2017 Oct;37(11):1067-1073
Rubino E et al
2017/01/01
PubMed
199 Rzepka R et al. Diagnostic Potential of Evaluation of SDF-1α and sRAGE Levels in Threatened Premature Labor. Biomed Res Int 2016;2016:2719460
Rzepka R et al
2016/01/01
PubMed
200 Sadashiv et al. Over expression of resistin in adipose tissue of the obese induces insulin resistance. World J Diabetes 2012 Jul;3(7):135-41
Sadashiv et al
2012/01/01
PubMed
201 Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
Šenolt L et al
2011/01/01
PubMed
202 Shaw KA et al. Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys. Contraception 2013 Jul;88(1):177-82
Shaw KA et al
2013/01/01
PubMed
203 Spanos N et al. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Obes Facts 2012;5(4):495-504
Spanos N et al
2012/01/01
PubMed
204 Tat RM et al. Resistin-Can it be a new early marker for prognosis in patients who survive after a cardiac arrest? A pilot study. PLoS ONE 2019;14(1):e0210666
Tat RM et al
2019/01/01
PubMed
205 Terra X et al. Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women. Cell Physiol Biochem 2010;26(6):1041-50
Terra X et al
2010/01/01
PubMed
206 Terra X et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011 Apr;164(4):539-47
Terra X et al
2011/01/01
PubMed
207 Thomopoulos C et al. Association of resistin and adiponectin with different clinical blood pressure phenotypes. J Hum Hypertens 2011 Jan;25(1):38-46
Thomopoulos C et al
2011/01/01
PubMed
208 Trachta P et al. Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients. Mol Cell Endocrinol 2014 Mar;383(1-2):96-102
Trachta P et al
2014/01/01
PubMed
209 Turnbull CD et al. Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomized control trials. Respirology 2017 05;22(4):793-799
Turnbull CD et al
2017/01/01
PubMed
210 Wohl P et al. Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. Eur J Endocrinol 2010 Oct;163(4):573-83
Wohl P et al
2010/01/01
PubMed
211 W坦jcik K et al. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C. World J. Gastroenterol. 2014 Aug;20(30):10449-56
W坦jcik K et al
2014/01/01
PubMed
212 Younossi ZM et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;18(11):1430-7
Younossi ZM et al
2008/01/01
PubMed
213 Zayani N et al. Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers. J Clin Lab Anal 2018 Feb;32(2)
Zayani N et al
2018/01/01
PubMed
214 de Luis DA et al. Effect of the rs1862513 variant of resistin gene on insulin resistance and resistin levels after two hypocaloric diets with different fat distribution in subjects with obesity. Eur Rev Med Pharmacol Sci 2018 Jun;22(12):3865-3872
de Luis DA et al
2018/01/01
PubMed
215 da Silva TE et al. Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis. Ann Hepatol 2018 Mar;17(2):286-299
da Silva TE et al
2018/01/01
PubMed
216 Rezaei Esfahrood Z et al. Evaluation of Resistin Levels in Saliva of Patients with Chronic Periodontitis and Healthy Subjects. Chin J Dent Res 2018;21(2):143-146
Rezaei Esfahrood Z et al
2018/01/01
PubMed
217 Szewczyk-Golec K et al. Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet. Oxid Med Cell Longev 2017;2017:8494107
Szewczyk-Golec K et al
2017/01/01
PubMed
218 Park JH et al. Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study. Medicine (Baltimore) 2017 Aug;96(33):e7854
Park JH et al
2017/01/01
PubMed
219 Ozkok A et al. CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients. BMC Nephrol 2017 Jul;18(1):250
Ozkok A et al
2017/01/01
PubMed
220 Becer E et al. Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects. Balkan J. Med. Genet. 2017 Jun;20(1):71-80
Becer E et al
2017/01/01
PubMed
221 Paduszyナгka A et al. Cardioprotective properties of leptin in patients with excessive body mass. Ir J Med Sci 2020 Nov;189(4):1259-1265
Paduszyナгka A et al
2020/01/01
PubMed
222 Saracevic A et al. Haemolysis and lipemia interfere with resistin and myeloperoxidase BioVendor ELISA assays. Biochem Med (Zagreb) 2019 Jun;29(2):020703
Saracevic A et al
2019/01/01
PubMed
223 Bulum T et al. Preserved C-peptide secretion in patients with type 1 diabetes and incipient chronic complications is associated with lower serum resistin and higher uric acid levels. J Diabetes Metab Disord 2020 Dec;19(2):1185-1189
Bulum T et al
2020/01/01
PubMed
224 CzogaナB W et al. <i>FTO</i> and <i>PLAG1</i> Genes Expression and <i>FTO</i> Methylation Predict Changes in Circulating Levels of Adipokines and Gastrointestinal Peptides in Children. Nutrients 2021 Oct;13(10)
CzogaナB W et al
2021/01/01
PubMed
225 Chaciナгka M et al. The Impact of OMEGA-3 Fatty Acids Supplementation on Insulin Resistance and Content of Adipocytokines and Biologically Active Lipids in Adipose Tissue of High-Fat Diet Fed Rats. Nutrients 2019 Apr;11(4)
Chaciナгka M et al
2019/01/01
PubMed
226 Lambova SN et al. Serum Leptin and Resistin Levels in Knee Osteoarthritis-Clinical and Radiologic Links: Towards Precise Definition of Metabolic Type Knee Osteoarthritis. Biomedicines 2021 Aug;9(8)
Lambova SN et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Fain JN et al. Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 2003 Jan;300(3):674-8
    Fain JN et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hegele RA et al. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler. Thromb. Vasc. Biol. 2003 Jan;23(1):111-6
    Hegele RA et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Stejskal D et al. Preliminary experience with resistin assessment in common population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002 Dec;146(2):47-9
    Stejskal D et al
    2002/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Yura S et al. Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 2003 Mar;88(3):1394-7
    Yura S et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Yannakoulia M et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 2003 Apr;88(4):1730-6
    Yannakoulia M et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Silha JV et al. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin. Endocrinol. (Oxf) 2003 Jun;58(6):736-42
    Silha JV et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kielstein JT et al. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am. J. Kidney Dis. 2003 Jul;42(1):62-6
    Kielstein JT et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Azuma K et al. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 2003 Aug;11(8):997-1001
    Azuma K et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Monzillo LU et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 2003 Sep;11(9):1048-54
    Monzillo LU et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    . Abstracts of the 18th International Diabetes Federation Congress. Paris, France, 24-29 August 2003. Diabetes Metab. 2003 Aug;29 Spec No 2:4S7-464

    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Furuhashi M et al. Circulating resistin levels in essential hypertension. Clin. Endocrinol. (Oxf) 2003 Oct;59(4):507-10
    Furuhashi M et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Silha JV et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 2003 Oct;149(4):331-5
    Silha JV et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Sch辰ffler A et al. Adipocytokines in synovial fluid. JAMA 2003 Oct;290(13):1709-10
    Sch辰ffler A et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lee JH et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subj
    Lee JH et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Degawa-Yamauchi M et al. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 2003 Nov;88(11):5452-5
    Degawa-Yamauchi M et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Fujinami A et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 2004 Jan;339(1-2):57-63
    Fujinami A et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Krsek M et al. Adipokine levels in Cushing&#39;s syndrome; elevated resistin levels in female patients with Cushing&#39;s syndrome. Clin. Endocrinol. (Oxf) 2004 Mar;60(3):350-7
    Krsek M et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Bajaj M et al. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int. J. Obes. Relat. Metab. Disord. 2004 Jun;28(6):783-9
    Bajaj M et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Stejskal D et al. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Nov;147(1):63-9
    Stejskal D et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Stejskal D et al. Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):167-72
    Stejskal D et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Hana V et al. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin. Endocrinol. (Oxf) 2004 Apr;60(4):442-50
    Hana V et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Heilbronn LK et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004 Apr;89(4):1844-8
    Heilbronn LK et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Al-Mrayat M et al. A new cause of neuroglycopenia: &quot;missing the point&quot;. Diabet. Med. 2004 May;21(5):497
    Al-Mrayat M et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Silha JV et al. Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet. Med. 2004 May;21(5):497-9
    Silha JV et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Vozarova de Courten B et al. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004 May;53(5):1279-84
    Vozarova de Courten B et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Tejero ME et al. Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons. Obes. Res. 2004 May;12(5):871-7
    Tejero ME et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Vendrell J et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 2004 Jun;12(6):962-71
    Vendrell J et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Meier U et al. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 2004 Sep;50(9):1511-25
    Meier U et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Azuma K et al. Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm. Metab. Res. 2004 Aug;36(8):564-70
    Azuma K et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Wolfe BE et al. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin. Endocrinol. (Oxf) 2004 Sep;61(3):332-8
    Wolfe BE et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Chen D et al. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin. Sci. 2005 Jan;108(1):81-4
    Chen D et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Shetty GK et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004 Oct;27(10):2450-7
    Shetty GK et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Sch辰ffler A et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm. Metab. Res. 2004 Oct;36(10):702-7
    Sch辰ffler A et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Lehrke M et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004 Nov;1(2):e45
    Lehrke M et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Housova J et al. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J. Clin. Endocrinol. Metab. 2005 Mar;90(3):1366-70
    Housova J et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Svensson J et al. Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults. J. Clin. Endocrinol. Metab. 2005 Apr;90(4):2290-6
    Svensson J et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Reilly MP et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 Feb;111(7):932-9
    Reilly MP et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Housov叩 J et al. Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res 2005;54(1):73-8
    Housov叩 J et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Carmina E et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur. J. Endocrinol. 2005 Mar;152(3):389-94
    Carmina E et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Chen CC et al. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metab. Clin. Exp. 2005 Apr;54(4):471-5
    Chen CC et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Bokarewa M et al. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005 May;174(9):5789-95
    Bokarewa M et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Pagano C et al. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. J. Clin. Endocrinol. Metab. 2005 Jul;90(7):4335-40
    Pagano C et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Sopasakis VR et al. Cytokine release from adipose tissue of nonobese individuals. Int J Obes (Lond) 2005 Sep;29(9):1144-7
    Sopasakis VR et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Gerber M et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4503-9
    Gerber M et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Pilz S et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4792-6
    Pilz S et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Verhaeghe J et al. Adipokine profile and C-reactive protein in pregnancy: effects of glucose challenge response versus body mass index. J. Soc. Gynecol. Investig. 2005 Jul;12(5):330-4
    Verhaeghe J et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Faeh D et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005 Jul;54(7):1907-13
    Faeh D et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Ohmori R et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J. Am. Coll. Cardiol. 2005 Jul;46(2):379-80
    Ohmori R et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Bo S et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond) 2005 Nov;29(11):1315-20
    Bo S et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Vilarrasa N et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin. Endocrinol. (Oxf) 2005 Sep;63(3):329-35
    Vilarrasa N et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Haugen F et al. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am. J. Physiol. Endocrinol. Metab. 2006 Feb;290(2):E326-33
    Haugen F et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    N端sken KD et al. Circulating resistin concentrations in children depend on renal function. Nephrol. Dial. Transplant. 2006 Jan;21(1):107-12
    N端sken KD et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Burnett MS et al. The potential role of resistin in atherogenesis. Atherosclerosis 2005 Oct;182(2):241-8
    Burnett MS et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Musso G et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005 Nov;42(5):1175-83
    Musso G et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Burnett MS et al. Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J. Clin. Endocrinol. Metab. 2006 Jan;91(1):64-8
    Burnett MS et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Perseghin G et al. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 2005 Dec;48(12):2615-21
    Perseghin G et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Pischon T et al. Association of plasma resistin levels with coronary heart disease in women. Obes. Res. 2005 Oct;13(10):1764-71
    Pischon T et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Wong SP et al. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C. Diabetologia 2005 Dec;48(12):2641-9
    Wong SP et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Bergheim I et al. Metformin prevents endotoxin-induced liver injury after partial hepatectomy. J. Pharmacol. Exp. Ther. 2006 Mar;316(3):1053-61
    Bergheim I et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Chu MC et al. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am. J. Obstet. Gynecol. 2006 Jan;194(1):100-4
    Chu MC et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Pagano C et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):1081-6
    Pagano C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Pravenec M et al. Fat-specific transgenic expression of resistin in the spontaneously hypertensive rat impairs fatty acid re-esterification. Int J Obes (Lond) 2006 Jul;30(7):1157-9
    Pravenec M et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Nystr旦m T et al. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin. Sci. 2006 Jun;110(6):673-81
    Nystr旦m T et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Koebnick C et al. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism. Int J Obes (Lond) 2006 Jul;30(7):1097-103
    Koebnick C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Bahr MJ et al. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2006 Aug;291(2):E199-206
    Bahr MJ et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Beulens JW et al. The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring) 2006 Jan;14(1):60-6
    Beulens JW et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Rae C et al. Human resistin promotes macrophage lipid accumulation. Diabetologia 2006 May;49(5):1112-4
    Rae C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Carmina E et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am. J. Med. 2006 Apr;119(4):356.e1-6
    Carmina E et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Lu HL et al. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J. Gastroenterol. 2006 Mar;12(11):1747-51
    Lu HL et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Menzaghi C et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J. Clin. Endocrinol. Metab. 2006 Jul;91(7):2792-5
    Menzaghi C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Perseghin G et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am. J. Physiol. Endocrinol. Metab. 2006 Oct;291(4):E697-703
    Perseghin G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Perseghin G et al. Increased serum resistin in elite endurance athletes with high insulin sensitivity. Diabetologia 2006 Aug;49(8):1893-900
    Perseghin G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Redondo C et al. The retinol-binding protein system: a potential paradigm for steroid-binding globulins? Horm. Metab. Res. 2006 Apr;38(4):269-78
    Redondo C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Yagmur E et al. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am. J. Gastroenterol. 2006 Jun;101(6):1244-52
    Yagmur E et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Paul G et al. Profiling adipocytokine secretion from creeping fat in Crohn&#39;s disease. Inflamm. Bowel Dis. 2006 Jun;12(6):471-7
    Paul G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Gambino R et al. RETRACTED: Postprandial lipemia and LDL conjugated dienes predict serum GGT and liver histology in NASH. Atherosclerosis 2006 Jun;
    Gambino R et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Lubos E et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis 2007 Jul;193(1):121-8
    Lubos E et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Westphal S et al. Extended-release niacin raises adiponectin and leptin. Atherosclerosis 2007 Aug;193(2):361-5
    Westphal S et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Kremen J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4620-7
    Kremen J et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Martos-Moreno GA et al. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur. J. Endocrinol. 2006 Sep;155(3):429-34
    Martos-Moreno GA et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Musso G et al. Retraction: The Postprandial Phase as a Link Between Systemic Lipid Peroxidation and Liver Injury in NASH. Am. J. Gastroenterol. 2006 Sep;
    Musso G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Risch L et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin. Chim. Acta 2007 Feb;376(1-2):108-13
    Risch L et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Perseghin G et al. Serum resistin and hepatic fat content in nondiabetic individuals. J. Clin. Endocrinol. Metab. 2006 Dec;91(12):5122-5
    Perseghin G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    de Luis Roman D et al. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch. Med. Res. 2006 Oct;37(7):854-9
    de Luis Roman D et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Westphal S et al. Adipokines and treatment with niacin. Metab. Clin. Exp. 2006 Oct;55(10):1283-5
    Westphal S et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Senolt L et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann. Rheum. Dis. 2007 Apr;66(4):458-63
    Senolt L et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Chu MC et al. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil. Steril. 2006 Dec;86(6):1669-75
    Chu MC et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Pamuk GE et al. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp. Oncol. 2006 Sep;28(3):241-4
    Pamuk GE et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Dolezalov叩 R et al. Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus. Physiol Res 2007;56(6):741-8
    Dolezalov叩 R et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Garcia AL et al. Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Horm. Metab. Res. 2006 Nov;38(11):761-6
    Garcia AL et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Hui-Bing H et al. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2006 Dec;55(12):1670-3
    Hui-Bing H et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Efstathiou SP et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin. Chim. Acta 2007 Mar;378(1-2):78-85
    Efstathiou SP et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Nagaev I et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006;1:e31
    Nagaev I et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Anderlov叩 K et al. Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes. Physiol Res 2007;56(5):579-86
    Anderlov叩 K et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Migita K et al. The serum levels of resistin in rheumatoid arthritis patients. Clin. Exp. Rheumatol. ;24(6):698-701
    Migita K et al
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    de Luis DA et al. Effects of a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults. Horm. Res. 2007;67(6):296-300
    de Luis DA et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Sch辰ffler A et al. Potential of adipocytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: pilot study. J. Gastroenterol. Hepatol. 2007 Mar;22(3):326-34
    Sch辰ffler A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Pilz S et al. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin. Endocrinol. (Oxf) 2007 Mar;66(3):380-6
    Pilz S et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Cortelazzi D et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf) 2007 Mar;66(3):447-53
    Cortelazzi D et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Kadoglou NP et al. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007 Mar;30(3):719-21
    Kadoglou NP et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Mojiminiyi OA et al. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand. J. Clin. Lab. Invest. 2007;67(2):215-25
    Mojiminiyi OA et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Perseghin G et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care 2007 Jun;30(6):1520-6
    Perseghin G et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Busetto L et al. The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 2008 Feb;18(2):112-20
    Busetto L et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Sund辿n-Cullberg J et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit. Care Med. 2007 Jun;35(6):1536-42
    Sund辿n-Cullberg J et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Derosa G et al. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone. J Clin Pharm Ther 2007 Jun;32(3):261-8
    Derosa G et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Tauman R et al. Adipokines in children with sleep disordered breathing. Sleep 2007 Apr;30(4):443-9
    Tauman R et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Chen D et al. Serum resistin in gestational diabetes mellitus and early postpartum. Clin. Endocrinol. (Oxf) 2007 Aug;67(2):208-11
    Chen D et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Kadoglou NP et al. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care 2007 Sep;30(9):2242-4
    Kadoglou NP et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Escriv叩 F et al. Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity. J. Endocrinol. 2007 Jul;194(1):131-41
    Escriv叩 F et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Weikert C et al. Within-subject variation of plasma resistin levels over a 1-year period. Clin. Chem. Lab. Med. 2007;45(7):899-902
    Weikert C et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Kovacić D et al. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure. Clin Res Cardiol 2008 Jan;97(1):24-31
    Kovacić D et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Kr鱈zov叩 J et al. Adiponectin and resistin gene polymorphisms in patients with anorexia nervosa and obesity and its influence on metabolic phenotype. Physiol Res 2008;57(4):539-46
    Kr鱈zov叩 J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Hoefle G et al. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin. Chim. Acta ;386(1-2):1-6
    Hoefle G et al
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Zhou L et al. Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. FEBS Lett. 2007 Sep;581(22):4303-8
    Zhou L et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Ellington AA et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 2007 Oct;50(4):708-14
    Ellington AA et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Musso G et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am. J. Clin. Nutr. 2007 Sep;86(3):661-
    Musso G et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Gambino R et al. Microsomal triglyceride transfer protein 493-T variant is associated with resistin levels and C-reactive protein. Clin. Biochem. 2007 Nov;40(16-17):1219-24
    Gambino R et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Kim SJ et al. Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J. Biol. Chem. 2007 Nov;282(47):34139-47
    Kim SJ et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Corpeleijn E et al. Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM). Diabetes Care 2007 Dec;30(12):3125-7
    Corpeleijn E et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Krusinov叩 E et al. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur. J. Endocrinol. 2007 Oct;157(4):443-9
    Krusinov叩 E et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Aller R et al. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig. Dis. Sci. 2008 Apr;53(4):1088-92
    Aller R et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Dolezalova R et al. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clin. Endocrinol. (Oxf) 2007 Nov;67(5):674-8
    Dolezalova R et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Lamounier-Zepter V et al. Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Mol. Cell. Endocrinol. 2008 Jan;280(1-2):39-46
    Lamounier-Zepter V et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Musso G et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008 Mar;31(3):562-8
    Musso G et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    de Luis DA et al. Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch. Med. Res. 2008 Jan;39(1):110-4
    de Luis DA et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Jarrar MH et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008 Mar;27(5):412-21
    Jarrar MH et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Kakizaki S et al. Elevated plasma resistin concentrations in patients with liver cirrhosis. J. Gastroenterol. Hepatol. 2008 Jan;23(1):73-7
    Kakizaki S et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Annaloro C et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 May;41(9):797-804
    Annaloro C et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Megia A et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur. J. Endocrinol. 2008 Feb;158(2):173-8
    Megia A et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Musso G et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 2008 Apr;47(4):1167-77
    Musso G et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Chalvatzas N et al. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil. Steril. 2009 Apr;91(4):1189-94
    Chalvatzas N et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Karapanagiotou EM et al. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer 2008 Sep;61(3):391-7
    Karapanagiotou EM et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Barac A et al. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension. Am. J. Cardiol. 2008 Apr;101(7):980-5
    Barac A et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Saito T et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J. Dent. Res. 2008 Apr;87(4):319-22
    Saito T et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    de Luis DA et al. Influence of Lys656Asn polymorphism of the leptin receptor gene on insulin resistance in nondiabetic obese patients. J. Diabetes Complicat. ;22(3):199-204
    de Luis DA et al
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Weikert C et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J. Clin. Endocrinol. Metab. 2008 Jul;93(7):2647-53
    Weikert C et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Koch TC et al. Obesity-related promotion of aberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemia rather than hyperinsulinemia. Eur J Nutr 2008 Apr;47(3):161-70
    Koch TC et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    Dost叩lov叩 I et al. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2008 Sep;93(9):3627-32
    Dost叩lov叩 I et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    Dolinkov叩 M et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol. Cell. Endocrinol. 2008 Sep;291(1-2):63-70
    Dolinkov叩 M et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Tsochatzis E et al. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Scand. J. Gastroenterol. 2008;43(9):1128-36
    Tsochatzis E et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Mangge H et al. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2009 Mar;203(1):277-83
    Mangge H et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Cell culture medium
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Haluz鱈kov叩 D et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009;58(4):577-81
    Haluz鱈kov叩 D et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    J淡rgensen SB et al. Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 2009 Jul;297(1):E57-66
    J淡rgensen SB et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    Koch A et al. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009;13(3):R95
    Koch A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Iacobellis G et al. Adipokines and cardiometabolic profile in primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 2010 May;95(5):2391-8
    Iacobellis G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    Durovcov叩 V et al. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing&#39;s syndrome. Physiol Res 2010;59(6):963-71
    Durovcov叩 V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Tuttolomondo A et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 2010;9:50
    Tuttolomondo A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Gupta A et al. Interleukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: potential risk of metabolic syndrome. Hum Exp Toxicol 2011 Oct;30(10):1445-53
    Gupta A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Aknc A et al. Association of cardiac changes with serum adiponectin and resistin levels in obese and overweight children. J Cardiovasc Med (Hagerstown) 2013 Mar;14(3):228-34
    Aknc A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Aller R et al. Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. Nutr Hosp ;25(4):572-6
    Aller R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Asgeirsson T et al. Serum adiponectin, resistin, and circulating soluble receptor for advanced glycation end products in colectomy patients. Mediators Inflamm. 2011;2011:916807
    Asgeirsson T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 152
  • 文献情報:
    Auguet T et al. Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque. BMC Cardiovasc Disord 2016 07;16(1):149
    Auguet T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 153
  • 文献情報:
    Auguet T et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011 Apr;12:60
    Auguet T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 154
  • 文献情報:
    Bahijri SM et al. Supplementation with Oligonol, Prevents Weight Gain and Improves Lipid Profile in Overweight and Obese Saudi Females. Curr Nutr Food Sci 2018 Apr;14(2):164-170
    Bahijri SM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 155
  • 文献情報:
    BOSANSKA L et al. The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol Res 2009;58(3):319-25
    BOSANSKA L et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 156
  • 文献情報:
    Broch M et al. Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Physiol Res 2010;59(2):299-303
    Broch M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 157
  • 文献情報:
    de Luis DA et al. Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets. J. Nut
    de Luis DA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 158
  • 文献情報:
    de Luis DA et al. Evaluation of weight loss and adipocytokines levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs9939609 gene variant. Diabetes Metab. Res. Rev. 2012 Nov;28(8):663-8
    de Luis DA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 159
  • 文献情報:
    de Luis DA et al. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. Eur Rev Med Pharmacol Sci ;13(6):413-8
    de Luis DA et al
  • 備考:
  • 参照:
    PubMed
  • No.: 160
  • 文献情報:
    Antonio de Luis D et al. The rs10401670 variant in resistin gene improved insulin resistance response and metabolic parameters secondaries to weight loss after a hypocaloric diet. Clin Nutr ESPEN 2016 08;14:14-18
    Antonio de Luis D et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 161
  • 文献情報:
    de Luis DA et al. Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets. Ann. Nutr. Metab. 2009;54(2):104-10
    de Luis DA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 162
  • 文献情報:
    De Luis DA et al. Resistin levels and inflammatory markers in patients with morbid obesity. Nutr Hosp ;25(4):630-4
    De Luis DA et al
  • 備考:
  • 参照:
    PubMed
  • No.: 163
  • 文献情報:
    de Luis DA et al. Lack of association of serum resistin levels with metabolic syndrome criteria in obese female patients. Clin. Biochem. 2011 Nov;44(16):1280-3
    de Luis DA et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 164
  • 文献情報:
    de Luis DA et al. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity. J Nutrigenet Nutrigenomics 2016;9(5-6):213-221
    de Luis DA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 165
  • 文献情報:
    de Luis DA et al. Polymorphism of neuropeptide Y gene rs16147 modifies the response to a hypocaloric diet on cardiovascular risk biomarkers and adipokines. J Hum Nutr Diet 2017 04;30(2):159-165
    de Luis DA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 166
  • 文献情報:
    de Luis DA et al. rs1501299 Polymorphism in the Adiponectin Gene and Their Association with Total Adiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects. Ann. Nutr. Metab. 2016;69(3-4):226-231
    de Luis DA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 167
  • 文献情報:
    Derosa G et al. Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. J Pharm Pharm Sci 2010;13(3):378-90
    Derosa G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 168
  • 文献情報:
    Derosa G et al. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens. Res. 2011 Jan;34(1):145-51
    Derosa G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 169
  • 文献情報:
    Derosa G et al. Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern. Med. 2010;49(16):1717-25
    Derosa G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 170
  • 文献情報:
    D鱈az-Soto G et al. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study. Diabetes Res. Clin. Pract. 2014 Apr;104(1):92-6
    D鱈az-Soto G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 171
  • 文献情報:
    ト志rovcovテ。 V et al. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing&#39;s syndrome. Physiol Res 2010;59(3):415-422
    ト志rovcovテ。 V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 172
  • 文献情報:
    Filkov叩 M et al. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann. Rheum. Dis. 2009 Feb;68(2):295-6
    Filkov叩 M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 173
  • 文献情報:
    Garcia JM et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 2011 Jun;12(1):80
    Garcia JM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 174
  • 文献情報:
    Gharibeh MY et al. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 2010 Dec;36(6 Pt 1):443-9
    Gharibeh MY et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 175
  • 文献情報:
    Gungor H et al. Association between resistin level and renal function in patients undergoing coronary artery bypass graft surgery. J Investig Med 2012 Aug;60(6):883-7
    Gungor H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 176
  • 文献情報:
    Gupta V et al. Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome. Toxicol Int 2011 Jul;18(2):168-72
    Gupta V et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 177
  • 文献情報:
    Hulejov叩 H et al. No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. Clin. Rheumatol. 2012 Jan;31(1):67-71
    Hulejov叩 H et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 178
  • 文献情報:
    Jurcovicov叩 J et al. Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis. Gen Physiol Biophys 2010 Mar;29(1):79-84
    Jurcovicov叩 J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 179
  • 文献情報:
    Kisacik B et al. Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acute appendicitis? Clin Rheumatol 2012 Feb;31(2):225-9
    Kisacik B et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 180
  • 文献情報:
    Kleiblova P et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 2010 Jan;314(1):150-6
    Kleiblova P et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 181
  • 文献情報:
    Kopeck箪 J et al. Selected adipokines - plasma concentrations and adipose tissue expressions during 24-hour lipid infusion in healthy men. Physiol Res 2010;59(1):89-96
    Kopeck箪 J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 182
  • 文献情報:
    Lien LF et al. The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. OMICS 2009 Feb;13(1):21-35
    Lien LF et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 183
  • 文献情報:
    Liu X et al. Plasma Resistin Levels in Patients with Acute Aortic Dissection: A Propensity Score-Matched Observational Case-Control Study. Med Sci Monit 2018 Sep;24:6431-6437
    Liu X et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 184
  • 文献情報:
    Mangge H et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795
    Mangge H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 185
  • 文献情報:
    Menzaghi C et al. Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals. Sci Rep 2017 Mar;7:44337
    Menzaghi C et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 186
  • 文献情報:
    Menzaghi C et al. Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals. PLoS One 2012;7(6):e38414
    Menzaghi C et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 187
  • 文献情報:
    Mojiminiyi OA et al. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract 2009;18(2):123-9
    Mojiminiyi OA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 188
  • 文献情報:
    Musso G et al. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty l
    Musso G et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 189
  • 文献情報:
    Mutakin et al. Association between selenium nutritional status and metabolic risk factors in men with visceral obesity. J Trace Elem Med Biol 2013 Apr;27(2):112-6
    Mutakin et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 190
  • 文献情報:
    Nakajima H et al. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch. Dermatol. Res. 2011 Aug;303(6):451-5
    Nakajima H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 191
  • 文献情報:
    Newgard CB et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009 Apr;9(4):311-26
    Newgard CB et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 192
  • 文献情報:
    Papadopoulos DP et al. Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels. J Clin Hypertens (Greenwich) 2009 Feb;11(2):61-5
    Papadopoulos DP et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 193
  • 文献情報:
    Pirola CJ et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2013 Sep;62(9):1356-63
    Pirola CJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 194
  • 文献情報:
    Qi Q et al. Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels. Hum Mol Genet 2012 Nov;21(21):4774-80
    Qi Q et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 195
  • 文献情報:
    Rank M et al. The cardio-metabolic risk of moderate and severe obesity in children and adolescents. J Pediatr 2013 Jul;163(1):137-42
    Rank M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 196
  • 文献情報:
    Roderburg C et al. Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. J Crit Care 2013 Oct;28(5):882.e1-11
    Roderburg C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 197
  • 文献情報:
    Rozmilowska I et al. What is the role of adipokines in myasthenia gravis? Ther Clin Risk Manag 2018;14:1515-1525
    Rozmilowska I et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 198
  • 文献情報:
    Rubino E et al. Investigating the role of adipokines in chronic migraine. Cephalalgia 2017 Oct;37(11):1067-1073
    Rubino E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 199
  • 文献情報:
    Rzepka R et al. Diagnostic Potential of Evaluation of SDF-1&#x3B1; and sRAGE Levels in Threatened Premature Labor. Biomed Res Int 2016;2016:2719460
    Rzepka R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 200
  • 文献情報:
    Sadashiv et al. Over expression of resistin in adipose tissue of the obese induces insulin resistance. World J Diabetes 2012 Jul;3(7):135-41
    Sadashiv et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 201
  • 文献情報:
    Šenolt L et al. Adipokine profile is modulated in subcutaneous adipose tissue by TNF&#x3B1; inhibitors in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 Nov;70(11):2054-6
    Šenolt L et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 202
  • 文献情報:
    Shaw KA et al. Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys. Contraception 2013 Jul;88(1):177-82
    Shaw KA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 203
  • 文献情報:
    Spanos N et al. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Obes Facts 2012;5(4):495-504
    Spanos N et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 204
  • 文献情報:
    Tat RM et al. Resistin-Can it be a new early marker for prognosis in patients who survive after a cardiac arrest? A pilot study. PLoS ONE 2019;14(1):e0210666
    Tat RM et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 205
  • 文献情報:
    Terra X et al. Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women. Cell Physiol Biochem 2010;26(6):1041-50
    Terra X et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 206
  • 文献情報:
    Terra X et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011 Apr;164(4):539-47
    Terra X et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 207
  • 文献情報:
    Thomopoulos C et al. Association of resistin and adiponectin with different clinical blood pressure phenotypes. J Hum Hypertens 2011 Jan;25(1):38-46
    Thomopoulos C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 208
  • 文献情報:
    Trachta P et al. Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients. Mol Cell Endocrinol 2014 Mar;383(1-2):96-102
    Trachta P et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 209
  • 文献情報:
    Turnbull CD et al. Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomized control trials. Respirology 2017 05;22(4):793-799
    Turnbull CD et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 210
  • 文献情報:
    Wohl P et al. Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. Eur J Endocrinol 2010 Oct;163(4):573-83
    Wohl P et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 211
  • 文献情報:
    W坦jcik K et al. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C. World J. Gastroenterol. 2014 Aug;20(30):10449-56
    W坦jcik K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 212
  • 文献情報:
    Younossi ZM et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;18(11):1430-7
    Younossi ZM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 213
  • 文献情報:
    Zayani N et al. Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers. J Clin Lab Anal 2018 Feb;32(2)
    Zayani N et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 214
  • 文献情報:
    de Luis DA et al. Effect of the rs1862513 variant of resistin gene on insulin resistance and resistin levels after two hypocaloric diets with different fat distribution in subjects with obesity. Eur Rev Med Pharmacol Sci 2018 Jun;22(12):3865-3872
    de Luis DA et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 215
  • 文献情報:
    da Silva TE et al. Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis. Ann Hepatol 2018 Mar;17(2):286-299
    da Silva TE et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 216
  • 文献情報:
    Rezaei Esfahrood Z et al. Evaluation of Resistin Levels in Saliva of Patients with Chronic Periodontitis and Healthy Subjects. Chin J Dent Res 2018;21(2):143-146
    Rezaei Esfahrood Z et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 217
  • 文献情報:
    Szewczyk-Golec K et al. Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet. Oxid Med Cell Longev 2017;2017:8494107
    Szewczyk-Golec K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 218
  • 文献情報:
    Park JH et al. Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study. Medicine (Baltimore) 2017 Aug;96(33):e7854
    Park JH et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 219
  • 文献情報:
    Ozkok A et al. CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients. BMC Nephrol 2017 Jul;18(1):250
    Ozkok A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 220
  • 文献情報:
    Becer E et al. Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor &#x3B3;2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects. Balkan J. Med. Genet. 2017 Jun;20(1):71-80
    Becer E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 221
  • 文献情報:
    Paduszyナгka A et al. Cardioprotective properties of leptin in patients with excessive body mass. Ir J Med Sci 2020 Nov;189(4):1259-1265
    Paduszyナгka A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 222
  • 文献情報:
    Saracevic A et al. Haemolysis and lipemia interfere with resistin and myeloperoxidase BioVendor ELISA assays. Biochem Med (Zagreb) 2019 Jun;29(2):020703
    Saracevic A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 223
  • 文献情報:
    Bulum T et al. Preserved C-peptide secretion in patients with type 1 diabetes and incipient chronic complications is associated with lower serum resistin and higher uric acid levels. J Diabetes Metab Disord 2020 Dec;19(2):1185-1189
    Bulum T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 224
  • 文献情報:
    CzogaナB W et al. <i>FTO</i> and <i>PLAG1</i> Genes Expression and <i>FTO</i> Methylation Predict Changes in Circulating Levels of Adipokines and Gastrointestinal Peptides in Children. Nutrients 2021 Oct;13(10)
    CzogaナB W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 225
  • 文献情報:
    Chaciナгka M et al. The Impact of OMEGA-3 Fatty Acids Supplementation on Insulin Resistance and Content of Adipocytokines and Biologically Active Lipids in Adipose Tissue of High-Fat Diet Fed Rats. Nutrients 2019 Apr;11(4)
    Chaciナгka M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 226
  • 文献情報:
    Lambova SN et al. Serum Leptin and Resistin Levels in Knee Osteoarthritis-Clinical and Radiologic Links: Towards Precise Definition of Metabolic Type Knee Osteoarthritis. Biomedicines 2021 Aug;9(8)
    Lambova SN et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed